Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics

Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics

Objective: Atypical antipsychotics (AAPs) promote obesity and insulin resistance. In this regard, the main objective of this study was to present potential mechanisms and evidence concerning side effects of atypical antipsychotics in humans and rodents. Method: A systematic review of the literatur...

Full description

Bibliographic Details
Main Authors:	Ana Maria Volpato, Alexandra Ioppi Zugno, João Quevedo
Format:	Article
Language:	English
Published:	Associação Brasileira de Psiquiatria (ABP) 2013-09-01
Series:	Brazilian Journal of Psychiatry
Subjects:	Neuroendocrinology schizophrenia drug side effects antipsychotics biological markers
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462013000300295&lng=en&tlng=en

Similar Items

Identification of Antipsychotic Side Effects with Glassgow Antipsychotic Side-Effect Scale (GASS)
by: Dita Hasni, et al.
Published: (2020-08-01)

Evaluation of long acting, oral and combination antipsychotic treatments in patients with psychotic disorder (tur)
by: Yasir Şafak, et al.
Published: (2020-01-01)

Metformin for the Prevention of Weight Gain due to Atypical Antipsychotics
by: Nazmiye Kaya, et al.
Published: (2011-06-01)

Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
by: Diana Grajales, et al.
Published: (2019-10-01)

THE ROLE OF ATYPICAL ANTIPSYCHOTIC DECREASING AGGRESIVENESS IN SCHIZOPHRENIA
by: Juvita Novia Anggraini Maria
Published: (2013-03-01)

Atypical Antipsychotics Induced Metabolic Syndrome
by: Aysegul Demirel, et al.
Published: (2015-03-01)

Effects of the classical antipsychotic haloperidol and atypical anti-psychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats.
by: Fell, M.J., et al.
Published: (2009)

Problems with the Administration of Antipsychotic Drugs in Depot Formulations in the Treatment of Schizophrenia
by: Ranković Anica, et al.
Published: (2018-03-01)

Hematological Side Effects of Atypical Antipsychotic Drugs
by: Serap Erdogan
Published: (2009-10-01)

Comparative Study of the Effects of Atypical Antipsychotic Drugs on Plasma and Urine Biomarkers of Oxidative Stress in Schizophrenic Patients
by: Dietrich-Muszalska A, et al.
Published: (2021-02-01)

Antipsychotic Treatment Experiences of People with Schizophrenia: Patient Perspectives from an Online Survey
by: Doane MJ, et al.
Published: (2020-10-01)

Antipsychotic treatments; Focus on lurasidone
by: Tomiki eSumiyoshi
Published: (2013-08-01)

Antipsychotic-associated psoriatic rash – a case report
by: Camelia-Eugenia Bujor, et al.
Published: (2017-07-01)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-08-01)

Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
by: Leonid Mikhaylovich Bardenshteyn, et al.
Published: (2010-06-01)

Self-limiting atypical antipsychotics-induced edema: Clinical cases and systematic review
by: Musa Usman Umar, et al.
Published: (2016-01-01)

A comparison of depot and oral atypical antipsychotics in terms of metabolic syndrome markers
by: Demet Sağlam Aykut, et al.
Published: (2018-07-01)

Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
by: Xu H, et al.
Published: (2019-07-01)

Anti-Stress Properties of Atypical Antipsychotics
by: Alice Sanson, et al.
Published: (2020-10-01)

Frequency of the antipsychotic therapy acute side effects in the treatment of acute psychosis
by: Svjetlana Loga-Zec, et al.
Published: (2002-02-01)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
by: Sang Won Jeon, et al.
Published: (2017-10-01)

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand
by: Boonlue T, et al.
Published: (2016-04-01)

Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
by: Eiji Kirino
Published: (2017-11-01)

Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia
by: Andrea Fagiolini, et al.
Published: (2011-11-01)

The influence of typical and atypical antipsychotics on neurocognitive functions in patients with psychotic disorders
by: Javorac Jovan M., et al.
Published: (2019-01-01)

Prevalence and management practice of first generation antipsychotics induced side effects among schizophrenic patients at Amanuel Mental Specialized Hospital, central Ethiopia: cross-sectional study
by: Yirgalem Shewakena Wubeshet, et al.
Published: (2019-01-01)

Comparison of Prescribing Patterns for Typical and Atypical Antipsychotics in Patients with Schizophrenia Before and After the Publication of the Phase I "CATIE" Trial
by: Varga, Ross
Published: (2007)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
by: Ita Fitzgerald, et al.
Published: (2021-09-01)

The interaction of folate cycle enzyme genes and the risk of extrapyramidal side effects of antipsychotics
by: T. V. Zhilyaeva, et al.
Published: (2020-12-01)

Antipsychotic-Induced Weight Gain and Clinical Improvement: A Psychiatric Paradox
by: Clemente Garcia-Rizo
Published: (2020-11-01)

Biological Mechanism(s) Underpinning the Association between Antipsychotic Drugs and Weight Gain
by: Bruna Panizzutti, et al.
Published: (2021-09-01)

Models of treatment with antipsychotics of the schizophrenic patients
by: Svjetlana Loga-Zec, et al.
Published: (2005-11-01)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
by: Anastasiia S. Boiko, et al.
Published: (2021-05-01)

Onset of action of atypical and typical antipsychotics in the treatment of acute psychosis
by: Seyed Ghafur Mousavi, et al.
Published: (2013-01-01)

Effect of atypical antipsychotic on blood pressure in inpatients with schizophrenia of Prof. Dr. Soerojo Mental Health Hospital Magelang
by: Haafizah Dania, et al.
Published: (2019-01-01)

Metabolic and Endocrine Side Effects of Atypical Antipsychotic Drugs in Children and Adolescents
by: Aysegul Tahiroglu, et al.
Published: (2011-03-01)

An open-label prospective study to assess metabolic side effects with atypical and typical antipsychotic drugs in patients with schizophrenia
by: Prasanna Kumar Neredumilli, et al.
Published: (2014-01-01)

Use of atypical antipsychotics in the elderly: a clinical review
by: Gareri P, et al.
Published: (2014-08-01)

Effects of Steps to Success Exercise Program in Weight Management For Psychiatric Patients Taking Atypical Antipsychotic Drugs
by: Homelo V. Estoque
Published: (2020-10-01)

The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
by: Burkay Yakar, et al.
Published: (2016-08-01)